⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL704968 | 0.72 | — | — | |
| SCHEMBL5476453 | 0.69 | — | — | |
| SCHEMBL27637204 | 0.69 | — | — | |
| SCHEMBL4017650 | 0.67 | ALDH1A1 (0.31) | — | |
| SCHEMBL2655903 | 0.67 | — | — | |
| SCHEMBL25402418 | 0.67 | — | — | |
| SCHEMBL22492693 | 0.67 | — | — | |
| SCHEMBL30139059 | 0.65 | — | — | |
| SCHEMBL2684896 | 0.61 | — | — | |
| SCHEMBL15142389 | 0.61 | ALDH1A1 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20040029897-A1 | Frangible compounds for pathogen inactivation | CERUS CORPORATION (US) | 2004-02-12 | — | — | US | disclosed |
| EP-1364944-A1 | Frangible Compounds for Pathogen Inactivation | Cerus Corporation (US) | 2003-11-26 | — | — | EP | disclosed |
| EP-1021414-B1 | FRANGIBLE COMPOUNDS FOR PATHOGEN INACTIVATION | CERUS CORP (US) | 2003-06-18 | — | — | EP | disclosed |
| US-6514987-B1 | Useful for inactivating pathogens in a material, such as a blood product, and then degrades to breakdown products | CERUS CORPORATION | 2003-02-04 | — | — | US | disclosed |
| EP-1021414-A1 | FRANGIBLE COMPOUNDS FOR PATHOGEN INACTIVATION | Cerus Corporation (US) | 2000-07-26 | — | — | EP | disclosed |
| US-6093725-A | A BINDER FOR DEACTIVATING PATHOGENS IN A BLOOD SAMPLE TO BIND NUCLEIC ACID BY COVALENT LINKAGE | CERUS CORPORATION (US) | 2000-07-25 | — | — | US | disclosed |
| EP-1005531-A2 | METHOD OF TREATING LEUKOCYTES, LEUKOCYTE COMPOSITIONS AND METHODS OF USE THEREOF | Cerus Corporation (US) | 2000-06-07 | — | — | EP | disclosed |
| CN-1248245-A | Friable compounds for pathogen inactivation | CERUS CORP (US) | 2000-03-22 | — | — | CN | disclosed |
| WO-1999003976-A2 | METHOD OF TREATING LEUKOCYTES, LEUKOCYTE COMPOSITIONS AND METHODS OF USE THEREOF | CERUS CORPORATION (US) | 1999-01-28 | — | — | WO | disclosed |
| WO-1998030545-A9 | FRANGIBLE COMPOUNDS FOR PATHOGEN INACTIVATION | — | 1998-12-30 | — | — | WO | disclosed |
| WO-1998030545-A1 | FRANGIBLE COMPOUNDS FOR PATHOGEN INACTIVATION | CERUS CORPORATION (US) | 1998-07-16 | — | — | WO | disclosed |